bioengineering

Scientists say their new hydrogel triggered an unexpected response by the immune system that led to more effective skin healing.

The film collects chemical signals from sweat and converts them into electrical ones that can be processed and displayed on a watch.

Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy the virus.

The blood cells, part of the body's first line of defense against infection, have been notoriously difficult to genetically engineer.

The findings, from a study by a UCLA-led team, could inform the development of precision antibiotics.

The shields can be mass-produced using laser cutting and 3D injection molding, giving quick relief to health workers battling the pandemic.

The development by a UCLA-led research team works to keep blood sugar at normal levels.

LL37 molecules, which are found in the immune system, play an important but unexpected role in revving up the body’s self-defense response.

In a lab test, half of the mice that received the treatment after having a tumor removed survived for at least 60 days without the tumor regrowing.

When injected into mice that had acute myeloid leukemia, the combination therapy halted the disease from developing any further.

The early work demonstrates the promise of so-called “mechanoceuticals."

A research team led by a UCLA bioengineer has created a model to predict the effectiveness of potential treatments to help the immune system.

The availability of such cells — with properties similar to those from humans and other animals — should help scientists accelerate research on therapies for cancer and autoimmune diseases.

“Tissues are wonderfully complex structures, so to engineer artificial versions of them that function properly, we have to recreate their complexity,” said UCLA professor Ali Khademhosseini.

The research explains concepts that were described nearly 90 years ago but had remained poorly understood until now.

UCLA research published in the journal Proceedings of the National Academy of Sciences is the first proof that a single material can be both static and moving.

The finding could eventually be used to help address human diseases associated with an imbalanced regulation of mitochondria size – for example, Alzheimer’s or Parkinson’s.

In a clinical trial, a UCLA-led team used a biomaterial embedded with tiny gems to help tissue heal after the procedure.

The injectable hydrogel works by forming a scaffold inside a wound that new tissue can grow around.

Sam Emaminejad, assistant professor of electrical engineering at UCLA, has demonstrated that a wearable biosensor can be used in the diagnosis of cystic fibrosis, diabetes and other diseases.

A UCLA team creates a "smart" mobile tool that may be used to diagnose and treat serious infections and diseases.

A simple and inexpensive attachment could help to expand testing to regions with limited resources.

The peptide discovery by UCLA researchers and others has broad implications for biomedicine.

The NBC medical drama featured RAVEN, a surgical robotic system designed for minimally invasive surgery that is both realistic and futuristic.

UCLA biochemists have devised a way to convert sugar into a variety of useful chemical compounds without using cells and that could lead to the production of biofuels and pharmaceuticals.